DONGSUNG PHARMACEUTICAL CO.,LTD Logo

DONGSUNG PHARMACEUTICAL CO.,LTD

A Korean firm making pharmaceuticals, cosmetics, and popular hair care products for over 60 years.

002210 | KO

Overview

Corporate Details

ISIN(s):
KR7002210003
LEI:
Country:
South Korea
Address:
서울특별시 도봉구 도봉로 683 (방학동) 동성빌딩, 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Dongsung Pharmaceutical Co., Ltd. is a Korean company engaged in the manufacture and distribution of pharmaceuticals, cosmetics, and hair care products, with a history of over 60 years. The company's portfolio includes both prescription (ETC) and over-the-counter (OTC) medicines, with notable products like the gastrointestinal drug 'Jeongro-hwan'. In the consumer sector, Dongsung is well-known for its 'Seven-Ait' hair dye brand and a diverse line of cosmetics. The company focuses on developing nature-friendly products and is also active in research areas such as photodynamic therapy.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-15 00:00
Post-Annual General Meeting Information
임시주주총회결과
Korean 19.0 KB
2025-09-10 00:00
Legal Proceedings Report
소송등의제기ㆍ신청(경영권분쟁소송)
Korean 9.7 KB
2025-08-26 00:00
Legal Proceedings Report
소송등의판결ㆍ결정
Korean 6.7 KB
2025-08-25 00:00
Legal Proceedings Report
소송등의판결ㆍ결정
Korean 5.4 KB
2025-08-19 00:00
Proxy Solicitation & Information Statement
[기재정정]의결권대리행사권유참고서류
Korean 109.6 KB
2025-08-18 00:00
Legal Proceedings Report
소송등의제기ㆍ신청(경영권분쟁소송)
Korean 6.8 KB
2025-08-14 00:00
Major Shareholding Notification
[기재정정]주식등의대량보유상황보고서(일반)
Korean 91.0 KB
2025-08-14 00:00
Major Shareholding Notification
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Korean 27.7 KB
2025-08-14 00:00
Audit Report / Information
반기검토의견부적정또는의견거절
Korean 6.4 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 903.0 KB
2025-08-14 00:00
Regulatory News Service
상장적격성실질심사관련주요개선계획(자율공시)
Korean 3.9 KB
2025-08-13 00:00
Proxy Solicitation & Information Statement
[기재정정]의결권대리행사권유참고서류
Korean 79.7 KB
2025-08-13 00:00
Delisting Announcement
기타시장안내 (개선기간 부여 결정)
Korean 6.0 KB
2025-08-11 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
Korean 29.4 KB
2025-08-11 00:00
Proxy Solicitation & Information Statement
[기재정정]의결권대리행사권유참고서류
Korean 74.3 KB

Automate Your Workflow. Get a real-time feed of all DONGSUNG PHARMACEUTICAL CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DONGSUNG PHARMACEUTICAL CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DONGSUNG PHARMACEUTICAL CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ArcticZymes Technologies Logo
Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.
Norway
AZT
Arcturus Therapeutics Holdings Inc. Logo
Develops mRNA therapeutics and vaccines for rare respiratory, liver, and infectious diseases.
United States of America
ARCT
Arcus Biosciences, Inc. Logo
A clinical-stage biopharma developing small molecule and antibody combination therapies for cancer.
United States of America
RCUS
Arcutis Biotherapeutics, Inc. Logo
Develops and commercializes non-steroidal therapies for immune-mediated skin diseases.
United States of America
ARQT
ARDELYX, INC. Logo
Biopharma developing first-in-class drugs for cardiorenal and GI diseases like IBS-C and CKD.
United States of America
ARDX
ARECOR THERAPEUTICS PLC Logo
Biopharma firm enhancing drugs via reformulation for diabetes and pharmaceutical partners.
United Kingdom
AREC
argenx SE Logo
Develops first-in-class antibody therapies for severe autoimmune diseases.
Netherlands
1AE
Armata Pharmaceuticals, Inc. Logo
Developing bacteriophage therapeutics for antibiotic-resistant infections.
United States of America
ARMP
AroCell AB Logo
Develops and markets diagnostic tests for monitoring cancer and bacterial diseases.
Sweden
AROC
ArriVent BioPharma, Inc. Logo
A clinical-stage biopharma developing in-licensed oncology drugs for difficult-to-treat diseases.
United States of America
AVBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.